Clinical utility gene card for: trimethylaminuria.

A review of trimethylaminuria: (fish odor syndrome). J Clin Aesthet Dermatol (2013) 0.99

Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population. Br J Clin Pharmacol (2014) 0.83

Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet (1999) 2.07

Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos (2001) 1.96

Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nat Genet (1997) 1.83

Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet (1998) 1.58

Choline- and betaine-defined diets for use in clinical research and for the management of trimethylaminuria. J Am Diet Assoc (2004) 1.53

A genetic polymorphism of the N-oxidation of trimethylamine in humans. Clin Pharmacol Ther (1987) 1.44

Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res (2002) 1.34

Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. Curr Drug Metab (2003) 1.25

Flavin-containing monooxygenases: mutations, disease and drug response. Trends Pharmacol Sci (2008) 1.24

Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients. Life Sci (2004) 1.22

Trimethylaminuria and a human FMO3 mutation database. Hum Mutat (2003) 1.20

Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children. J Inherit Metab Dis (2006) 1.16

Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants. J Pharmacol Exp Ther (2006) 1.16

Trimethylaminuria: the detection of carriers using a trimethylamine load test. J Inherit Metab Dis (1989) 1.15

Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin Biochem Rev (2011) 1.12

Trimethylaminuria, fish odour syndrome: a new method of detection and response to treatment with metronidazole. J Inherit Metab Dis (1995) 1.10

Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. Am J Hum Genet (2001) 1.09

Transient trimethylaminuria related to menstruation. BMC Med Genet (2007) 1.08

Halitosis in medicine: a review. Int Dent J (2002) 1.07

Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants. Mol Pharmacol (2005) 1.05

Exacerbation of symptoms of fish-odour syndrome during menstruation. Lancet (1997) 1.05

Transient trimethylaminuria in childhood. Acta Paediatr (1998) 0.93

Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome. Pharmacogenetics (2000) 0.92

Studies on the discontinuous N-oxidation of trimethylamine among Jordanian, Ecuadorian and New Guinean populations. Pharmacogenetics (1997) 0.89

A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria. Pharmacogenetics (2001) 0.88

Psychosocial problems as the major complication of an adolescent with trimethylaminuria. J Pediatr (1979) 0.87

Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development. Pharmacogenomics (2005) 0.87

Trimethylaminuria (fish-odour syndrome) and oral malodour. Oral Dis (2005) 0.86

Fish odour syndrome with features of both primary and secondary trimethylaminuria. Clin Exp Dermatol (2003) 0.86

Biochemical and molecular studies in mild flavin monooxygenase 3 deficiency. J Inherit Metab Dis (2000) 0.86

Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria. Mol Genet Metab (2009) 0.86

Individuals reporting idiopathic malodor production: demographics and incidence of trimethylaminuria. Am J Med (2011) 0.85

A novel mutation in the flavin-containing monooxygenase 3 gene (FMO3) of a Norwegian family causes trimethylaminuria. Mol Genet Metab (2009) 0.80

Ability to detect malodour might be genetic. BMJ (1993) 0.79

A novel mutation in the flavin-containing monooxygenase 3 gene, FM03, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy. Pharmacogenetics (2000) 0.79

Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22

Outcomes of siblings with classical galactosemia. J Pediatr (2009) 1.26

Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics (2004) 1.23

Trimethylaminuria and a human FMO3 mutation database. Hum Mutat (2003) 1.20

Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos). Biochem Pharmacol (2004) 1.07

Galactosemia, a single gene disorder with epigenetic consequences. Pediatr Res (2010) 1.03

The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa. Pharmacogenet Genomics (2008) 0.95

Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria. Am J Med Genet A (2008) 0.93

Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3). Pharmacogenet Genomics (2007) 0.90

Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamide. Drug Metab Dispos (2008) 0.90

N-glycan abnormalities in children with galactosemia. J Proteome Res (2013) 0.89

Transfection of liver in vivo by biolistic particle delivery: its use in the investigation of cytochrome P450 gene regulation. Mol Biotechnol (2002) 0.88

Polymorphisms of the Flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in Caucasians. BMC Med Genet (2005) 0.88

Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure. Orphanet J Rare Dis (2012) 0.86

Genetic polymorphisms of flavin-containing monooxygenase (FMO). Drug Metab Rev (2002) 0.86

In-situ partitioning of butyltin compounds in estuarine sediments. Chemosphere (2004) 0.84

Glycogen storage disease type III in the Irish population. J Inherit Metab Dis (2010) 0.84

Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population. Br J Clin Pharmacol (2014) 0.83

Influence of organic waste and residue mud additions on chemical, physical and microbial properties of bauxite residue sand. Environ Sci Pollut Res Int (2010) 0.83

Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine. Pharmacogenet Genomics (2009) 0.82

Alternative promoters and repetitive DNA elements define the species-dependent tissue-specific expression of the FMO1 genes of human and mouse. Biochem J (2007) 0.81

Reversible multiorgan system involvement in a neonate with complex IV deficiency. Pediatr Neurol (2008) 0.81

Fertility preservation in female classic galactosemia patients. Orphanet J Rare Dis (2013) 0.80

Isolation of mouse hepatocytes. Methods Mol Biol (2013) 0.80

The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism. Expert Opin Drug Metab Toxicol (2010) 0.79

Geochemical partitioning of copper, lead, and zinc in benthic, estuarine sediment profiles. J Environ Qual (2005) 0.77

Trace metal distribution and enrichment in benthic, estuarine sediments: Southport Broadwater, Australia. Environ Geochem Health (2005) 0.77

Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouse. Pharmaceuticals (Basel) (2012) 0.76

Isolation and Culture of Mouse Hepatocytes: Gender-Specific Gene Expression Responses to Chemical Treatments. Methods Mol Biol (2015) 0.76

Leptin levels in children and adults with classic galactosaemia. JIMD Rep (2012) 0.76

Sorption and desorption behavior of tributyltin with natural sediments. Environ Sci Technol (2004) 0.76

Tributyltin partitioning in sediments: effect of aging. Chemosphere (2005) 0.75

"Stiff neonate" with mitochondrial DNA depletion and secondary neurotransmitter defects. Pediatr Neurol (2011) 0.75

Clinical utility gene card for: Trimethylaminuria - update 2014. Eur J Hum Genet (2014) 0.75

Predictive hydrogeochemical modelling of bauxite residue sand in field conditions. J Hazard Mater (2011) 0.75

A highly sensitive liquid chromatography electrospray ionization mass spectrometry method for quantification of TMA, TMAO and creatinine in mouse urine. MethodsX (2017) 0.75

Reactive sulfide relationships with trace metal extractability in sediments from southern Moreton Bay, Australia. Mar Pollut Bull (2005) 0.75